Cahill Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$387K Sell
13,788
-95
-0.7% -$2.53K 0.04% 206
2025
Q4
$346K Sell
13,883
-8,401
-38% -$212K 0.04% 220
2025
Q3
$568K Buy
22,284
+517
+2% +$12.8K 0.06% 164
2025
Q2
$528K Buy
21,767
+4,087
+23% +$95.3K 0.07% 162
2025
Q1
$448K Buy
17,680
+2,396
+16% +$62.7K 0.06% 176
2024
Q4
$405K Buy
15,284
+5,756
+60% +$156K 0.06% 182
2024
Q3
$276K Buy
9,528
+162
+2% +$4.73K 0.04% 222
2024
Q2
$262K Sell
9,366
-259
-3% -$7.13K 0.04% 231
2024
Q1
$267K Buy
9,625
+1,101
+13% +$30.6K 0.04% 229
2023
Q4
$245K Sell
8,524
-1,109
-12% -$33.5K 0.04% 219
2023
Q3
$320K Buy
9,633
+1,920
+25% +$67.9K 0.05% 186
2023
Q2
$283K Buy
7,713
+325
+4% +$12.7K 0.05% 201
2023
Q1
$301K Buy
7,388
+2,235
+43% +$96.5K 0.05% 195
2022
Q4
$264K Buy
+5,153
New +$247K 0.05% 198
2021
Q4
Sell
-1,349
Closed -$58K 600
2021
Q3
$58K Buy
+1,349
New +$59.8K 0.01% 323

Other funds holding PFE

Cahill Financial Advisors's PFE Position: Q1 2026 in Review

Cahill Financial Advisors reduced its Pfizer (PFE) stake by 0.68% in Q1 2026, selling an estimated $2.53K and leaving 13,788 shares worth $387K. The position accounts for 0.04% of the portfolio, ranked #206.

Cahill Financial Advisors first reported a position in PFE in Q3 2021 and has held it in 15 quarters since. The position peaked at $568K in Q3 2025. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Cahill Financial Advisors held 13,788 shares of Pfizer worth $387K as of Q1 2026.
  • Cahill Financial Advisors sold 95 Pfizer shares in Q1 2026, an estimated $2.53K.
  • Pfizer made up 0.04% of Cahill Financial Advisors's portfolio in Q1 2026, its #206 holding.
  • Cahill Financial Advisors first reported a position in Pfizer in Q3 2021 and has held it in 15 quarters since.
  • Cahill Financial Advisors's Pfizer position peaked at $568K in Q3 2025.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Cahill Financial Advisors's 13F filing for Q1 2026, filed 13 May 2026.